Concepedia

Publication | Open Access

Duration by Design: Discovery of Revefenacin, the First-in-Class Nebulized Once-Daily Bronchodilator for the Treatment of Patients With COPD

10

Citations

0

References

2016

Year

No additional data available for this publication yet. Check back later!